Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Tags:
Roche, Amgen, Gilead, Sanofi, Celgene
These 2 Businesses Could Boost Sanofi's Top Line
Motley Fool
Sun, 11/3/13 - 12:10 pm
Tags:
Sanofi, diabetes, orphan drugs
1 Big Pharma Giant on the Verge of a Turnaround
Motley Fool
Sat, 11/2/13 - 11:58 am
Tags:
Sanofi
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
Sanofi Profit Forecast Eases Concern After Setbacks
Bloomberg
Wed, 10/30/13 - 09:42 am
Tags:
Sanofi, guidance
The Value Of Sanofi Lies In Its Predictability
Seeking Alpha
Tue, 10/29/13 - 09:32 am
Tags:
Sanofi
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
Tags:
patents, Copaxone, Teva, Nexium, AstraZeneca, Micardis, Boehringer Ingelheim, Sandostatin LAR, Novartis, Exforge, Nasonex, Merck, TriLipix, AbbVie, Evista, Eli Lilly, Restasis, Allergan, Renagel, Sanofi
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thu, 10/24/13 - 11:29 am
Tags:
Novo Nordisk, diabetes, Merck, Sanofi, NovoSeven, JNJ
3 Orphan Drugmakers to Watch
Motley Fool
Wed, 10/23/13 - 08:43 am
Tags:
orphan drugs, Biomarin, GSK, Vimizim, Tafinlar, Mekinist, Myozyme, Cerazyme, Sanofi
The Next Cholesterol-Fighting Blockbuster Drug?
Motley Fool
Sun, 10/20/13 - 02:44 pm
Tags:
cholesterol, hypercholesterolemia, Regeneron, Sanofi, alirocumab
Atchoo! Who’s making money out of flu season
CNBC
Fri, 10/18/13 - 09:34 am
Tags:
Flu, Novartis, GSK, Merck, Sanofi, AstraZeneca
Sanofi Cholesterol Drug Beats Merck’s Zetia in Late-Stage Study
Bloomberg
Wed, 10/16/13 - 08:03 am
Tags:
Sanofi, Zetia, Merck, alirocumab, Regeneron
Can Protalix Revolutionize This Orphan Disease?
Motley Fool
Tue, 10/15/13 - 05:01 pm
Tags:
orphan drugs, Protalix BioTherapeutics, Gaucher disease, Vpriv, Shire, Sanofi, Genzyme, Cerezyme, Elelyso
What Drugs? Sanofi Battles Employees In France Over R&D Job Cuts
Pharmalot
Tue, 10/15/13 - 10:21 am
Tags:
Sanofi, layoffs, R&D
Sanofi's home market France may be its biggest handicap
Reuters
Mon, 10/14/13 - 11:23 am
Tags:
Sanofi, R&D, France
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
Tags:
emerging markets, Bayer, Sanofi, Merck KGaA, GSK, Novartis, JNJ, Novo Nordisk, AstraZeneca, Pfizer, Roche
Sanofi gets US OK for nonprescription Nasacort
Bloomberg/Businessweek
Mon, 10/14/13 - 08:59 am
Tags:
Sanofi, OTC, Nasacort
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Wed, 10/9/13 - 03:58 pm
Tags:
Merck, Pfizer, Eli Lilly, Big Pharma, Sanofi, Roche, GSK, Abbott Laboratories, Melinta Therapeutics, antibiotics, delafloxacin
Ex-Celgene, Sanofi execs plead guilty on insider trading charges
Fierce Biotech
Wed, 10/9/13 - 11:28 am
Tags:
insider trading, Sanofi, Celgee
Sanofi’s Viehbacher Sees Return to Growth in Fourth Quarter
Bloomberg
Mon, 10/7/13 - 08:56 am
Tags:
Sanofi, Chris Viehbacher, Pharma CEOs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.